| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 5.239.305 $ | 95,51 | 302.101 | ||||||
| Dianthus Therapeutics Inc | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 292.854 $ | 5,34 | 2.739 | |
| Xenon Pharmaceuticals Inc | XENON PHARMACEUTICALS INC | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 267.225 $ | 4,87 | 4.264 | |
| Praxis Precision Medicines Inc | PRAXIS PRECISION MEDICINES INC | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 267.196 $ | 4,87 | 868 | |
| ACADIA PHARMACEUTICALS INC. | ACADIA PHARMACEUTICALS INC | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 257.381 $ | 4,69 | 9.949 | |
| ARROWHEAD PHARMACEUTICALS, INC. | ARROWHEAD PHARMACEUTICALS INC | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 255.304 $ | 4,65 | 3.016 | |
| ALKERMES PUBLIC LIMITED COMPANY | ALKERMES PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 252.445 $ | 4,60 | 5.153 | |
| Scholar Rock Holding Corp | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 235.482 $ | 4,29 | 4.979 | |
| BIOGEN INC. | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 229.131 $ | 4,18 | 1.129 | |
| NEUROCRINE BIOSCIENCES, INC. | NEUROCRINE BIOSCIENCES INC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 224.346 $ | 4,09 | 1.345 | |
| PTC THERAPEUTICS, INC. | PTC THERAPEUTICS INC | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 211.443 $ | 3,85 | 3.109 | |
| AXSOME THERAPEUTICS, INC. | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 206.873 $ | 3,77 | 949 | |
| Denali Therapeutics Inc | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 201.425 $ | 3,67 | 8.750 | |
| Dyne Therapeutics, Inc | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 195.498 $ | 3,56 | 7.764 | |
| Edgewise Therapeutics Inc | EDGEWISE THERAPEUTICS INC | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 177.354 $ | 3,23 | 4.615 | |
| SUPERNUS PHARMACEUTICALS, INC. | SUPERNUS PHARMACEUTICALS INC | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 142.905 $ | 2,61 | 3.202 | |
| AxoGen, Inc. | AXOGEN INC | EC | 05463X106 | Long | Börsenkurs (Stufe 1) | 128.361 $ | 2,34 | 3.041 | |
| SK Biopharmaceuticals Co Ltd | SK BIOPHARMACEUTICALS CO LTD | EC | Y806MN108 | Long | Modellwert (Stufe 2) | 126.095 $ | 2,30 | 2.295 | |
| H. LUNDBECK A/S | H LUNDBECK A S | EC | DK0061804770 | Long | Modellwert (Stufe 2) | 100.792 $ | 1,84 | 15.754 | |
| Biohaven Ltd | BIOHAVEN LTD | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 99.590 $ | 1,82 | 7.377 | |
| SAREPTA THERAPEUTICS, INC. | SAREPTA THERAPEUTICS INC | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 88.476 $ | 1,61 | 5.954 | |
| BioArctic AB | BIOARCTIC AB | EC | SE0010323311 | Long | Modellwert (Stufe 2) | 85.563 $ | 1,56 | 2.506 | |
| Taysha Gene Therapies Inc | TAYSHA GENE THERAPIES INC | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 82.034 $ | 1,50 | 13.999 | |
| Neuren Pharmaceuticals Ltd | NEUREN PHARMACEUTICALS LTD | EC | NZNEUE0001S8 | Long | Modellwert (Stufe 2) | 81.113 $ | 1,48 | 6.435 | |
| Idorsia Ltd | IDORSIA LTD | EC | CH0363463438 | Long | Modellwert (Stufe 2) | 78.965 $ | 1,44 | 10.423 | |
| Rapport Therapeutics Inc | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 68.560 $ | 1,25 | 1.673 | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | INTEGRA LIFESCIENCES HOLDINGS CORP | EC | 457985208 | Long | Börsenkurs (Stufe 1) | 65.185 $ | 1,19 | 3.915 | |
| Alto Neuroscience Inc | ALTO NEUROSCIENCE INC | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 49.971 $ | 0,91 | 1.846 | |
| LB Pharmaceuticals Inc | LB PHARMACEUTICALS INC | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 48.938 $ | 0,89 | 1.221 | |
| Dynavox Group AB | DYNAVOX GROUP AB | EC | SE0017105620 | Long | Modellwert (Stufe 2) | 43.886 $ | 0,80 | 5.818 | |
| Annexon Inc | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 42.696 $ | 0,78 | 8.380 | |
| Medincell SA | MEDINCELL SA | EC | FR0004065605 | Long | Modellwert (Stufe 2) | 41.256 $ | 0,75 | 1.372 | |
| Solid Biosciences Inc | SOLID BIOSCIENCES INC | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 37.068 $ | 0,68 | 4.599 | |
| Bright Minds Biosciences Inc | BRIGHT MINDS BIOSCIENCES INC | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 32.601 $ | 0,59 | 445 | |
| Relmada Therapeutics Inc | RELMADA THERAPEUTICS INC | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 28.759 $ | 0,52 | 5.416 | |
| Design Therapeutics Inc | DESIGN THERAPEUTICS INC | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 26.979 $ | 0,49 | 2.215 | |
| Regenxbio Inc | REGENXBIO INC | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 26.638 $ | 0,49 | 2.749 | |
| Oncolys Biopharma Inc | ONCOLYS BIOPHARMA INC | EC | J61461109 | Long | Modellwert (Stufe 2) | 26.307 $ | 0,48 | 1.600 | |
| Ceribell Inc | CERIBELL INC | EC | 15678C102 | Long | Börsenkurs (Stufe 1) | 25.597 $ | 0,47 | 1.447 | |
| NEUROGENE INC. | NEUROGENE INC | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 24.339 $ | 0,44 | 740 | |
| Clearpoint Neuro Inc | CLEARPOINT NEURO INC | EC | 18507C103 | Long | Börsenkurs (Stufe 1) | 23.486 $ | 0,43 | 1.572 | |
| Benitec Biopharma Inc | BENITEC BIOPHARMA INC | EC | 08205P209 | Long | Börsenkurs (Stufe 1) | 23.198 $ | 0,42 | 1.981 | |
| Prothena Corporation PLC | PROTHENA CORP PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 22.403 $ | 0,41 | 2.759 | |
| OVID THERAPEUTICS INC. | OVID THERAPEUTICS INC | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 21.705 $ | 0,40 | 9.777 | |
| MicroPort NeuroScientific Corp | MICROPORT NEUROSCIENTIFIC CORP | EC | KYG6083E1098 | Long | Modellwert (Stufe 2) | 21.657 $ | 0,39 | 19.000 | |
| Neuropace Inc | NEUROPACE INC | EC | 641288105 | Long | Börsenkurs (Stufe 1) | 19.889 $ | 0,36 | 1.543 | |
| SanBio Company Limited | SANBIO CO LTD | EC | JP3336750009 | Long | Modellwert (Stufe 2) | 19.555 $ | 0,36 | 3.400 | |
| Zylox-Tonbridge Medical Technology Co Ltd | ZYLOX TONBRIDGE MEDICAL TECHNOLOGY CO LTD | EC | CNE100004JD2 | Long | Modellwert (Stufe 2) | 19.417 $ | 0,35 | 8.000 | |
| VANDA PHARMACEUTICALS INC. | VANDA PHARMACEUTICALS INC | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 17.044 $ | 0,31 | 3.342 | |
| Newron Pharmaceuticals SpA | NEWRON PHARMACEUTICALS SPA | EC | T6916C102 | Long | Modellwert (Stufe 2) | 15.362 $ | 0,28 | 1.060 | |
| Anavex Life Sciences Corp | ANAVEX LIFE SCIENCES CORP | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 14.693 $ | 0,27 | 5.343 | |
| PEIJIA MEDICAL LIMITED | PEIJIA MEDICAL LTD | EC | G6981F109 | Long | Modellwert (Stufe 2) | 14.313 $ | 0,26 | 28.000 | |
| Santhera Pharmaceuticals Holding AG | SANTHERA PHARMACEUTICALS HOLDING AG | EC | H7155R142 | Long | Modellwert (Stufe 2) | 13.512 $ | 0,25 | 771 | |
| Inhibikase Therapeutics Inc | INHIBIKASE THERAPEUTICS INC | EC | 45719W205 | Long | Börsenkurs (Stufe 1) | 12.380 $ | 0,23 | 5.679 | |
| Capricor Therapeutics Inc | CAPRICOR THERAPEUTICS INC | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 11.846 $ | 0,22 | 3.077 | |
| Larimar Therapeutics Inc | LARIMAR THERAPEUTICS INC | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 11.491 $ | 0,21 | 3.008 | |
| TONIX PHARMACEUTICALS HOLDING CORP. | TONIX PHARMACEUTICALS HOLDING CORP | EC | 890260839 | Long | Börsenkurs (Stufe 1) | 9.540 $ | 0,17 | 953 | |
| Voyager Therapeutics Inc | VOYAGER THERAPEUTICS INC | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 9.332 $ | 0,17 | 3.080 | |
| Entrada Therapeutics Inc | ENTRADA THERAPEUTICS INC | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 9.017 $ | 0,16 | 1.328 | |
| AC Immune SA | AC IMMUNE SA | EC | H00263105 | Long | Börsenkurs (Stufe 1) | 8.285 $ | 0,15 | 3.783 | |
| Acumen Pharmaceuticals Inc | ACUMEN PHARMACEUTICALS INC | EC | 00509G209 | Long | Börsenkurs (Stufe 1) | 8.101 $ | 0,15 | 3.768 | |
| Alector Inc | ALECTOR INC | EC | 014442107 | Long | Börsenkurs (Stufe 1) | 7.191 $ | 0,13 | 4.762 | |
| Neumora Therapeutics Inc | NEUMORA THERAPEUTICS INC | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 7.065 $ | 0,13 | 4.388 | |
| Myung In Pharm Co Ltd | MYUNG IN PHARMA CO LTD | EC | Y6S5DX102 | Long | Modellwert (Stufe 2) | 6.241 $ | 0,11 | 212 | |
| PepGen Inc | PEPGEN INC | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 6.118 $ | 0,11 | 3.476 | |
| MapLight Therapeutics Inc | MAPLIGHT THERAPEUTICS INC | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 5.794 $ | 0,11 | 445 | |
| Cognition Therapeutics Inc | COGNITION THERAPEUTICS INC | EC | 19243B102 | Long | Börsenkurs (Stufe 1) | 4.041 $ | 0,07 | 4.543 | |
| Gesamt | 5.239.305 $ | 95,51 | 302.101 |